0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Allergy/Immunology
 21-22 of 22 Articles
Original Article |  FREE
Carlene A. Muto, MD, MS; Maria G. Sistrom, MSN; Barbara A. Strain, MA; et al.
Arch Surg. 2000;135(8):982-985. doi:10.1001/archsurg.135.8.982.

Paper |  FREE
Ann Lyons, MB, BCh; Andreas Goebel, MD, PhD; John A. Mannick, MD; et al.
Arch Surg. 1999;134(12):1317-1324. doi:10.1001/archsurg.134.12.1317.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Pediatrics
Viewpoint  | 
In the Aftermath of the National Children’s Study
James M. Perrin, MD; Sarosh P. Batlivala, MD; Tina L. Cheng, MD, MPH
JAMA Psychiatry
Research Letter  | 
Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia:  The Importance of Cross-Validation Studies
Lot D. de Witte, MD, PhD; Carolin Hoffmann, MSc; Hans C. van Mierlo, MD; et al.
JAMA Internal Medicine
Original Investigation  | 
The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma
Anupam B. Jena, MD, PhD; Oliver Ho, BA; Dana P. Goldman, PhD; et al.
JAMA Internal Medicine
Perspective  | 
Not Breathing Easier With the US FDA’s Ban on Chlorofluorocarbons in Inhalers
Rita F. Redberg, MD, MSc